BRTX vs NCLH · rev $359.7K vs P/E 16, rev $4.97B
BioRestorative Therapies Inc (BRTX) versus Norwegian Cruise Line Holdings Ltd (NCLH) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Latest reported BRTX revenue for 2025-12-31 was $359.7K. Net income was -$14.2M. Revenue was down 10.3% from 2024-12-31 to 2025-12-31. BRTX currently screens at market cap $10.2M.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
BRTX currently screens at market cap $10.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Not investment advice. Open the BRTX and NCLH stock pages for the full models.
Not investment advice.